Moderna is the latest company to produce a promising RSV vaccine By: MarketWatch January 18, 2023 at 12:23 PM EST The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial Read More >> Related Stocks: Johnson & Johnson Moderna Inc Pfizer
